Humacyte Forecast, price target & analysts
Humacyte Target price 2025 - Analyst rating & recommendation
Humacyte Classifications & Recommendation:
Humacyte Price Target
| Target Price | $3.57 |
| Price | $1.19 |
| Potential |
200.00%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Humacyte 2026 .
The average Humacyte target price is $3.57.
This is
200.00%
register free of charge
$26.25
2,105.88%
register free of charge
$3.03
154.62%
register free of charge
|
|
| A rating was issued by 13 analysts: 11 Analysts recommend Humacyte to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Humacyte stock has an average upside potential 2026 of
200.00%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 3.71 |
9 Analysts have issued a sales forecast Humacyte 2025 . The average Humacyte sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Humacyte EBITDA forecast 2025. The average Humacyte EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-107m | 15.68% |
|---|---|---|
| 2025 |
$-60.5m
43.37%
Unlock
|
|
EBITDA Margin
9 Humacyte Analysts have issued a net profit forecast 2025. The average Humacyte net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.26 | -0.35 |
| 17.76% | 72.22% | |
| P/E | negative | |
| EV/Sales | 54.48 |
9 Analysts have issued a Humacyte forecast for earnings per share. The average Humacyte EPS is
This results in the following potential growth metrics and future valuations:
Current Humacyte Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Oct 06 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 18 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Oct 06 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 18 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 15 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
